Metabolism of cydiastatin 4 and analogues by enzymes associated with the midgut and haemolymph of Manduca sexta larvae.
The degradation of synthetic cydiastatin 4 (ARPYSFGL-amide) and cydiastatin 4 analogues cydiastatin 4alpha (PPPPPARPYSFGL-amide) and cydiastatin 4beta (PPPPPARPYSF[Acpc]L-amide) by enzymes associated with the midgut and/or haemolymph of the tobacco hawkmoth moth, Manduca sexta was investigated using reversed-phase high performance liquid chromatography (RP-HPLC) combined with matrix assisted laser desorption ionisation-time of flight mass spectrometry (MALDI-TOF MS). Cydiastatin 4 had an estimated half-life of c. 16.5min when incubated with midgut tissue in vitro and c. 2.5min with midgut lumen contents. Two degradation products were identified; cydiastatin(1-6), due to cleavage of the C-terminal di-peptide GL-amide, and cydiastatin(2-8), due to cleavage of the N-terminal A residue. Both cydiastatin 4alpha and cydiastatin 4beta had increased stability to gut and haemolymph enzymes, and full biological activity, but reduced potency compared to cydiastatin 4 when assayed on foregut peristalsis. The P-extended N-terminus of both analogues prevented hydrolysis by aminopeptidases and the replacement of the susceptible G residue with cyclopropylalanine ([Acpc]) counteracted carboxypeptidase activity. However, both analogues were susceptible to amidase-like activity giving an increase in one mass unit presumably due to the conversion of the C-terminal amide group to the free carboxylic acid. No metabolism of cydiastatin 4beta occurred when incubated with larval M. sexta haemolymph over a 90min period.
Audsley
Neil
N
Central Science Laboratory, Sand Hutton, York YO41 1LZ, UK. n.audsley@csl.gov.uk
Matthews
June
J
Nachman
Ronald
R
Weaver
Robert J
RJ
D000818:Animals; D004064:Digestive System / Q000201:enzymology* / Q000378:metabolism; D006458:Hemolymph / Q000201:enzymology* / Q000378:metabolism; D007814:Larva / Q000201:enzymology / Q000378:metabolism; D018402:Manduca / Q000254:growth & development* / Q000378:metabolism*; D013058:Mass Spectrometry; D009479:Neuropeptides / Q000378:metabolism*
C518385:ARPYSFGL-NH2; D009479:Neuropeptides